ArticleGland surgery2025
Predictive factors for re-recurrence in papillary thyroid carcinoma following reoperation: a retrospective analysis.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combined Ultrasound and MRI Assessment in Patients Undergoing Reoperation for Recurrent Papillary Thyroid Carcinoma: Oncological Outcomes and Surgical Safety.Current oncology (Toronto, Ont.) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary thyroid carcinoma (PTC) generally has a favorable prognosis; however, recurrence occurs in up to 30% of cases following initial management. Re-recurrence presents additional clinical challenges, making it crucial to distinguish between persistent disease and true recurrence in order to optimize management strategies and improve patient outcomes. Despite its significance, studies focusing on the risk factors for re-recurrence in PTC are limited. This study aimed to identify the risk factors for re-recurrence in PTC patients who underwent total thyroidectomy and central neck dissection, with or without lateral neck dissection, as the initial operation. Methods: A retrospective review was conducted on the medical records of 158 PTC patients who underwent reoperation for recurrence at a single institution between February 2006 and October 2020. Predictive factors for re-recurrence were identified using Cox proportional hazards models and Kaplan-Meier survival analyses. Results: During a median follow-up of 101.3 months after reoperation, re-recurrence occurred in 27 (17.1%) patients. Univariate analysis revealed that initial T4 stage (P=0.006), initial lymph node ratio >0.7 (P=0.049), and unstimulated thyroglobulin (Tg) ≥1 ng/mL (P=0.02) were significantly associated with worse recurrence-free survival after reoperation. In multivariate analysis, T4a stage [ Conclusions: Short-term follow-up with appropriate imaging modalities is necessary for patients with T4a stage disease and for those who had elevated Tg levels after the first reoperation due to PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.